Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-04-17 @ 7:51 PM
Study NCT ID:
NCT03170960
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-17
First Post:
2017-05-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Exelixis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-23
First Submit QC Date:
None
Study First Post Date:
2017-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-13
Last Update Post Date:
2025-08-17
Last Update Post Date Type:
ACTUAL